Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study.

Saved in:
Bibliographic Details
Title: Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
Authors: Ngiam JN; Division of Infectious Diseases, Department of Medicine, National University Health System Singapore, 1E Kent Ridge Rd, NUHS Tower Block, Level 10, Singapore, 119228, Singapore. nicholas_ngiam@nuhs.edu.sg.; Communicable Diseases Agency, Singapore, Singapore. nicholas_ngiam@nuhs.edu.sg., Loy EX; National Centre for Infectious Diseases, Singapore, Singapore.; Communicable Diseases Agency, Singapore, Singapore., Koh MCY; Division of Infectious Diseases, Department of Medicine, National University Health System Singapore, 1E Kent Ridge Rd, NUHS Tower Block, Level 10, Singapore, 119228, Singapore., Chiew CJ; National Centre for Infectious Diseases, Singapore, Singapore.; Ministry of Health, Singapore, Singapore.; Communicable Diseases Agency, Singapore, Singapore., Li RJ; National Centre for Infectious Diseases, Singapore, Singapore.; Communicable Diseases Agency, Singapore, Singapore., Lim SC; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.; Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.; Diabetes Centre, Admiralty Medical Centre, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Tai ES; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Bee YM; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.; Department of Endocrinology, Singapore General Hospital, Singapore, Singapore., Chow WL; Ministry of Health, Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore., Lye DCB; National Centre for Infectious Diseases, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Communicable Diseases Agency, Singapore, Singapore., Chia YW; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Department of Cardiology, Tan Tock Seng Hospital, Singapore, Singapore., Chan MYY; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Cardiology, National University Heart Centre, Singapore, Singapore., Hausenloy DJ; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.; National Heart Research Institute Singapore, National Heart Centre, Singapore, Singapore.; The Hatter Cardiovascular Institute, University College London, London, UK., Tan KB; National Centre for Infectious Diseases, Singapore, Singapore.; Ministry of Health, Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Communicable Diseases Agency, Singapore, Singapore., Wee LE; National Centre for Infectious Diseases, Singapore, Singapore.; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.; Communicable Diseases Agency, Singapore, Singapore.
Source: Infectious diseases and therapy [Infect Dis Ther] 2026 Jul; Vol. 15 (7), pp. 1955-1976. Date of Electronic Publication: 2026 Jun 03.
Publication Type: Journal Article
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2193-8229
DOI:10.1007/s40121-026-01362-z